Lipovaxin-MM

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLipovaxin-MM

Drug Alias NameGSK-2401502

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLipotek Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLipotek Pty Ltd

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A